Beneficial Effects of Evogliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, on Adiposity with Increased Ppargc1a in White Adipose Tissue in Obese Mice.
PLoS One
; 10(12): e0144064, 2015.
Article
in En
| MEDLINE
| ID: mdl-26633898
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Piperazines
/
Transcription Factors
/
Adiposity
/
Adipose Tissue, White
/
Dipeptidyl-Peptidase IV Inhibitors
/
Obesity
Type of study:
Prognostic_studies
Limits:
Animals
Language:
En
Journal:
PLoS One
Year:
2015
Document type:
Article